Search
Now showing items 31-38 of 38
Clinical, immunological, virological characteristics, and hospitalisation outcomes of patients admitted to Kiruddu Hospital with advanced HIV disease
(Makerere University, 2022-08)
Introduction
Nearly four decades after the first case of AIDS was described, the global number of AIDS related deaths is not declining as expected to meet elimination targets, especially in sub-Saharan Africa where the ...
Correlation of plasma HIV-1 p24 antigen levels with viral load in samples of HIV positive patients on ART in Uganda
(Makerere University, 2022-12)
Globally, a total of 38.0 million people living with HIV, of which 1.7 million people became newly infected with HIV in 2019. Additionally, an average of 690,000 people died from AIDS-related illnesses in 2019, and 26 ...
Mobile Phone-based intervention to promote un-interrupted HIV treatment during the COVID-19 pandemic
(2022)
Introduction: Keeping HIV-infected adults away from the health care system during the COVID-19 travel restrictions, presents a challenge to HIV treatment adherence.
Methods: This study focused on the initial two phases ...
Prevalence and associated factors of HIV positive status disclosure to family members and the lived experiences by women attending Kalisizo General Hospital ART Clinic
(Makerere University, 2020)
Background: HIV is still an epidemic infection globally with 38 million infected with it. HIV positive status disclosure is an important factor in HIV/AIDS prevention interventions and plays a role in ART adherence. However, ...
Preferences, and perceived confidence and intention to complete 1HP and 3HP rifapentine-based tuberculosis preventive treatment regimens among people living with HIV at the Mulago ISS Clinic, Kampala, Uganda: a cross-sectional survey
(Makerere University, 2023)
Background: One month of daily and three months of weekly isoniazid-rifapentine (1HP and 3HP, respectively) have similar efficacy and safety profiles and have been recommended for the prevention of tuberculosis (TB) among ...
Viral non-suppression, perceptions and effectiveness of intensive adherence counselling among people living with HIV/AIDS on antiretroviral therapy with low-level Viraemia in Uganda
(Makerere University, 2023)
Background and significance: One of the major aspects of controlling HIV transmission is the Undetectable equals Untransmissible (U=U). This indicates that PLHIV who take ART well attain an effective and sustainable ...
HLA Class I and Pediatric HIV disease progression in Botswana and Uganda
(Makerere University, 2023)
Sub-Saharan Africa remains the global epicenter of the HIV epidemic; more than 70% (25 million) of all people living with HIV/AIDS are in Africa. To end the global epidemic, finding an effective HIV vaccine remains a top ...
Risk factors associated with sustained neurocognitive impairment among cryptococcal meningitis survivors; a retrospective analysis at two tertiary hospitals in Uganda
(Makerere University, 2023)
Background: Despite major progress in HIV therapy and management, cryptococcal meningitis (Mbonigaba et al.) remains an important cause of morbidity and mortality among people living with HIV (PLWHIV) in Uganda, including ...